Thermo Fisher Scientific Inc (TMO)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 74.68% | 74.81% | 55.12% | 55.45% | 38.09% | 36.42% | 54.89% | 53.79% | 56.27% | 57.83% | 58.00% | 55.70% | 75.37% | 67.60% | 57.96% | 50.52% | 45.30% | 45.44% | 45.48% | 45.56% |
| Operating profit margin | 16.56% | 16.26% | 15.79% | 16.60% | 18.98% | 21.10% | 23.13% | 24.50% | 26.44% | 27.53% | 28.53% | 28.25% | 24.60% | 21.20% | 17.33% | 18.19% | 18.37% | 18.27% | 18.39% | 16.25% |
| Pretax margin | 15.23% | 14.90% | 10.65% | 11.58% | 8.80% | 9.31% | 14.81% | 15.89% | 16.61% | 19.11% | 19.74% | 18.81% | 22.80% | 26.36% | 23.14% | 24.29% | 24.40% | 24.59% | 24.89% | 22.69% |
| Net profit margin | 14.48% | 14.07% | 9.88% | 10.48% | 7.21% | 7.61% | 12.47% | 13.40% | 13.68% | 15.72% | 16.15% | 15.33% | 20.12% | 24.61% | 22.23% | 22.65% | 22.91% | 22.76% | 22.88% | 21.57% |
Thermo Fisher Scientific Inc.'s profitability ratios have shown a declining trend over the past quarters. The gross profit margin has decreased from 42.24% in Q4 2022 to 39.90% in Q4 2023, indicating lower profitability on sales after accounting for the cost of goods sold.
Similarly, the operating profit margin has also decreased steadily from 18.94% in Q4 2022 to 17.08% in Q4 2023, showing a reduction in the company's ability to generate operating profit from sales. The pretax margin and net profit margin followed the same pattern, both declining over the quarters.
These deteriorating profitability ratios could be a cause for concern and may indicate challenges faced by Thermo Fisher Scientific Inc. in managing costs and enhancing operational efficiency. Further analysis of the company's financial performance and strategies may be needed to address these downward trends and improve profitability in the future.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 6.95% | 7.07% | 7.13% | 7.54% | 8.64% | 10.02% | 10.64% | 10.57% | 10.54% | 14.35% | 15.82% | 15.07% | 11.29% | 9.30% | 7.27% | 7.80% | 7.87% | 7.95% | 7.72% | 7.05% |
| Return on assets (ROA) | 6.07% | 6.12% | 4.46% | 4.76% | 3.28% | 3.61% | 5.74% | 5.78% | 5.46% | 8.19% | 8.95% | 8.18% | 9.23% | 10.79% | 9.32% | 9.72% | 9.81% | 9.90% | 9.60% | 9.35% |
| Return on total capital | 14.68% | 15.15% | 15.34% | 16.88% | 19.08% | 20.83% | 22.79% | 23.93% | 24.58% | 27.28% | 19.25% | 18.51% | 14.54% | 11.25% | 8.86% | 9.58% | 9.83% | 9.86% | 15.58% | 14.14% |
| Return on equity (ROE) | 12.83% | 13.11% | 9.60% | 10.66% | 7.25% | 7.51% | 12.29% | 13.09% | 12.73% | 15.58% | 16.45% | 15.37% | 18.47% | 21.72% | 19.21% | 19.97% | 19.31% | 19.14% | 19.38% | 18.78% |
Thermo Fisher Scientific Inc.'s profitability ratios show a general trend of decreasing profitability over the quarters analyzed.
Operating return on assets (Operating ROA) has declined from 10.77% in Q1 2022 to 7.41% in Q4 2023. This indicates the company's ability to generate operating income from its assets has decreased over time.
Return on assets (ROA) has also shown a similar downward trend, falling from 8.20% in Q1 2022 to 6.07% in Q4 2023. This suggests a decrease in the company's overall efficiency in generating profits from its total assets.
Return on total capital has followed a similar pattern, declining from 13.42% in Q1 2022 to 8.89% in Q4 2023. This ratio indicates the company's ability to generate profits from both equity and debt investments has weakened over the periods analyzed.
Return on equity (ROE) has also experienced a decreasing trend, dropping from 18.56% in Q1 2022 to 12.83% in Q4 2023. This decrease signifies a lower return to shareholders on their equity investments in the company.
Overall, Thermo Fisher Scientific Inc.'s profitability ratios indicate a decline in profitability and efficiency in utilizing its assets and capital for generating returns for shareholders over the quarters analyzed.
See also:
Thermo Fisher Scientific Inc Profitability Ratios (Quarterly Data)